CJC-1295 [no DAC] 5mg

CJC-1295 (No DAC) — Research Peptide

CJC-1295 (No DAC) is a synthetic peptide supplied for laboratory research purposes and represents a modified analogue of growth hormone–releasing hormone (GHRH). Within scientific literature, this compound has been referenced in studies examining receptor interactions and associated cellular signalling mechanisms under controlled experimental conditions.

The “No DAC” designation indicates the absence of a drug affinity complex modification, resulting in different experimental handling characteristics compared with DAC-modified variants. Provided as a lyophilised material, CJC-1295 (No DAC) is utilised within laboratory environments where precise preparation and controlled handling are required for research workflows.

Research Areas of Interest

Scientific literature referencing CJC-1295 (No DAC) includes investigation into areas such as:

• Experimental examination of receptor-associated cellular signalling processes within laboratory models
• Investigation of peptide interactions examined in endocrine-related research environments
• Evaluation of cellular response pathways studied under controlled experimental conditions
• Comparative research examining differences between DAC-modified and non-modified peptide variants within laboratory systems

These areas reflect ongoing scientific exploration and position CJC-1295 (No DAC) as a subject of continued laboratory research interest.

Technical Information

Product Name: CJC-1295 (No DAC)
Chemical Name: CJC-1295 (No DAC)
Synonyms: Modified GRF (1-29); Tetrasubstituted GRF (1-29)
Molecular Formula: C₁₆₅H₂₇₁N₄₇O₄₆
Molecular Weight: ~3367.9 g/mol
Amino Acid Sequence: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn
CAS Number: 863288-34-0
Classification: Synthetic growth hormone–releasing hormone analogue research peptide
Form: Lyophilised powder

Storage Guidelines

Lyophilised material remains stable at room temperature for short periods during laboratory handling.

For extended storage, material should be maintained at −20 °C or below. Following reconstitution, solutions should be stored refrigerated and handled according to standard laboratory protocols.

Solubility

CJC-1295 (No DAC) is typically soluble in sterile laboratory water, acetic acid, or suitable aqueous buffers depending on laboratory preparation requirements.

References

Teichman, S. L., et al. (2006). Studies examining growth hormone–releasing hormone analogue activity within controlled experimental models. Journal of Clinical Endocrinology & Metabolism, 91(3), 799–805.

Additional literature entries referencing Modified GRF (1–29) are available within peptide research databases.

Research Use Notice

This product is supplied strictly for laboratory research purposes only. It is not intended for human or veterinary consumption, therapeutic application, or diagnostic use. Products supplied are not medicines, food products, or cosmetic ingredients.